Associations of place characteristics with HIV and HCV risk behaviors among racial/ethnic groups of people who inject drugs in the United States

Annals of Epidemiology

Volumn 26, Issue 9, 2016, Pages 619-630.e2

  Linton, Sabriya L ^a   Cooper, Hannah L F ^a   Kelley, Mary E ^a   Karnes, Conny C ^a   Ross, Zev ^b   Wolfe, Mary E ^a   Chen, Yen Tyng ^a   Friedman, Samuel R ^c   Des Jarlais, Don ^d   Semaan, Salaam ^e   Tempalski, Barbara ^c   Sionean, Catlainn ^e   DiNenno, Elizabeth ^e   Wejnert, Cyprian ^e   Paz Bailey, Gabriela ^e   Taussig, Jennifer ^f   Johnson, Shacara ^f   Todd, Jeff ^f   Flynn, Colin ^f   German, Danielle ^f   Isenberg, Debbie ^f   Driscoll, Maura ^f   Hurwitz, Elizabeth ^f   Prachand, Nikhil ^f   Benbow, Nanette ^f   Melville, Sharon ^f   Yeager, Richard ^f   Dyer, Jim ^f   Novoa, Alicia ^f   Thrun, Mark ^f   Al Tayyib, Alia ^f   Higgins, Emily ^f   Mokotoff, Eve ^f   Griffin, Vivian ^f   Sayegh, Aaron ^f   Risser, Jan ^f   Rehman, Hafeez ^f   Bingham, Trista ^f   Sey, Ekow Kwa ^f   Metsch, Lisa ^f   Forrest, David ^f   Beck, Dano ^f   Cardenas, Gabriel ^f   Nemeth, Chris ^f   Smith, Lou ^f   Watson, Carol Ann ^f   Robinson, William T ^f   Gruber, DeAnn ^f   Barak, Narquis ^f   Neaigus, Alan ^f   Jenness, Samuel ^f   Wendel, Travis ^f   Gelpi Acosta, Camila ^f   Hagan, Holly ^f   Godette, Henry ^f   Bolden, Barbara ^f   D'Errico, Sally ^f   Brady, Kathleen A ^f   Kirkland, Althea ^f   Shpaner, Mark ^f   Miguelino Keasling, Vanessa ^f   Velasco, Al ^f   Raymond, H Fisher ^f   De Leo'n, Sandra Miranda ^f   Rolo'n Colo'n, Yadira ^f   Courogen, Maria ^f   Thiede, Hanne ^f   Burt, Richard ^f   Herbert, Michael ^f   Friedberg, Yelena ^f   Wrigley, Dale ^f   Fisher, Jacob ^f   Sansone, Marie ^f   West Ojo, Tiffany ^f   Magnus, Manya ^f   Kuo, Irene ^f   more..

^a EMORY UNIVERSITY   (United States)

^b ZEVROSS SPATIAL ANALYSIS   (United States)

^c NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

^d BETH ISRAEL MEDICAL CENTER   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f NONE

Author keywords

Condom use; Drug treatment; HCV; HIV; Housing; Injection drug use; PWID

Indexed keywords

ANTIVIRUS AGENT;

ADULT; ARTICLE; BLACK PERSON; CAUCASIAN; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FEMALE; HEALTH BEHAVIOR; HEALTH CARE ACCESS; HEPATITIS C; HIGH RISK POPULATION; HISPANIC; HOUSING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; NAMED GROUPS OF PERSONS; PEOPLE WHO INJECT DRUG; PHARMACEUTICAL CARE; PRIORITY JOURNAL; RESIDENTIAL HOME; RISK ASSESSMENT; RISK FACTOR; SOCIAL BEHAVIOR; UNITED STATES; UNSAFE SEX; ANCESTRY GROUP; CHRONIC HEPATITIS C; CLINICAL TRIAL; COMMUNICABLE DISEASE CONTROL; ETHNIC GROUP; GEOGRAPHY; HEALTH SURVEY; HIGH RISK BEHAVIOR; INCIDENCE; MULTICENTER STUDY; NEEDS ASSESSMENT; PATIENT SAFETY; PROCEDURES; PSYCHOLOGY; SEXUAL BEHAVIOR; STATISTICS AND NUMERICAL DATA; SUBSTANCE ABUSE; YOUNG ADULT;

ADULT; COMMUNICABLE DISEASE CONTROL; CONTINENTAL POPULATION GROUPS; ETHNIC GROUPS; FEMALE; GEOGRAPHY; HEALTH SURVEYS; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; NEEDS ASSESSMENT; PATIENT SAFETY; RISK ASSESSMENT; RISK-TAKING; SEXUAL BEHAVIOR; SUBSTANCE ABUSE, INTRAVENOUS; UNITED STATES; YOUNG ADULT;

EID: 84991702119     PISSN: 10472797     EISSN: 18732585     Source Type: Journal    
DOI: 10.1016/j.annepidem.2016.07.012     Document Type: Article

References (94)

1. [1] Tempalski, B., Lieb, S., Cleland, C.M., Cooper, H., Brady, J.E., Friedman, S.R., HIV prevalence rates among injection drug users in 96 large US metropolitan areas, 1992-2002. J Urban Health 86 (2009), 132–154.
2. [2] Diagnoses of HIV infection and AIDS in the United States: HIV surveillance report, Vol. 21, 2011, US Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA.
3. [3] Des Jarlais, D.C., Semaan, S., HIV prevention for injecting drug users: the first 25 years and counting. Psychosom Med 70 (2008), 606–611.
4. [4] Des Jarlais, D.C., Perlis, T., Friedman, S.R., Chapman, T., Kwok, J., Rockwell, R., et al. Behavioral risk reduction in a declining HIV epidemic: injection drug users in New York City, 1990-1997. Am J Public Health 90 (2000), 1112–1116.
5. [5] Des Jarlais, D.C., Marmor, M., Friedman, P., Titus, S., Aviles, E., Deren, S., et al. HIV incidence among injection drug users in New York City, 1992-1997: evidence for a declining epidemic. Am J Public Health 90 (2000), 352–359.
6. [6] CDC. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 U.S. dependent areas—2010. HIV Surveill Suppl Rep, 17(No.3, part A.), 2012.
7. [7] CDC. Centers for Disease Control and Prevention. Viral Hepatitis Surveillance, United States, 2009. 2011 Available at: http://www.cdc.gov/hepatitis/statistics/2009surveillance/.
8. [8] Armstrong, G.L., Wasley, A., Simard, E.P., McQuillan, G.M., Kuhnert, W.L., Alter, M.J., The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 144 (2006), 705–714.
9. [9] Conrad, C., Bradley, H.M., Broz, D., Buddha, S., Chapman, E.L., Galang, R.R., et al. Community outbreak of HIV infection linked to injection drug use of oxymorphone–Indiana, 2015. MMWR Morb Mortal Wkly Rep 64 (2015), 443–444.
10. [10] Suryaprasad, A.G., White, J.Z., Xu, F., Eichler, B.-A., Hamilton, J., Patel, A., et al. Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006–2012. Clin Infect Dis 59 (2014), 1411–1419.
11. [11] Use of enhanced surveillance for hepatitis C virus infection to detect a cluster among young injection-drug users—New York, November 2004-April 2007. MMWR Morb Mortal Wkly Rep 57 (2008), 517–521.
12. [12] Notes from the field: risk factors for hepatitis C virus infections among young adults—Massachusetts, 2010. MMWR Morb Mortal Wkly Rep 60 (2011), 1457–1458.
13. [13] Notes from the field: hepatitis C virus infections among young adults—rural Wisconsin, 2010. MMWR Morb Mortal Wkly Rep, 61, 2012, 358.
14. [14] Spiller, M.W., Broz, D., Wejnert, C., Nerlander, L., Paz-Bailey, G., HIV infection and HIV-associated behaviors among persons who inject drugs—20 cities, United States, 2012. MMWR Morb Mortal Wkly Rep 64 (2015), 270–275.
15. [15] Linton, S.L., Celentano, D.D., Kirk, G.D., Mehta, S.H., The longitudinal association between homelessness, injection drug use, and injection-related risk behavior among persons with a history of injection drug use in Baltimore, MD. Drug Alcohol Depend 132 (2013), 457–465.
16. [16] Milloy, M.J., Kerr, T., Salters, K., Samji, H., Guillemi, S., Muntaner, J., et al. Incarceration is associated with used syringe lending among active injection drug users with detectable plasma HIV-1 RNA: a longitudinal analysis. BMC Infect Dis, 13, 2013, 565.
17. [17] Bourgois, P., The moral economies of homeless heroin addicts: confronting ethnography, HIV risk, and everyday violence in San Francisco shooting encampments. Subst Use Misuse 33 (1998), 2323–2351.
18. [18] Rhodes, T., The ‘risk environment’: a framework for understanding and reducing drug-related harm. Int J Drug Policy 13 (2002), 85–94.
19. [19] Rhodes, T., Risk environments and drug harms: a social science for harm reduction approach. Int J Drug Policy 20 (2009), 193–201.
20. [20] Rhodes, T., Singer, M., Bourgois, P., Friedman, S.R., Strathdee, S.A., The social structural production of HIV risk among injecting drug users. Soc Sci Med 61 (2005), 1026–1044.
21. [21] Cooper, H., Des Jarlais, D., Ross, Z., Tempalski, B., Bossak, B., Friedman, S., Spatial access to sterile syringes and the odds of injecting with an unsterile syringe among injectors: a longitudinal multilevel study. J Urban Health 89 (2012), 678–696.
22. [22] Cooper, H.L., Des Jarlais, D.C., Ross, Z., Tempalski, B., Bossak, B., Friedman, S.R., Spatial access to syringe exchange programs and pharmacies selling over-the-counter syringes as predictors of drug injectors’ use of sterile syringes. Am J Public Health 101 (2011), 1118–1125.
23. [23] Williams, C.T., Metzger, D.S., Race and distance effects on regular syringe exchange program use and injection risks: a geobehavioral analysis. Am J Public Health 100 (2010), 1068–1074.
24. [24] Galea, S., Vlahov, D., Social determinants and the health of drug users: socioeconomic status, homelessness, and incarceration. Public Health Rep 117 (2002), S135–S145.
25. [25] Bluthenthal, R.N., Kral, A.H., Gee, L., Erringer, E.A., Edlin, B.R., The effect of syringe exchange use on high-risk injection drug users: a cohort study. AIDS 14 (2000), 605–611.
26. [26] Gibson, D.R., Brand, R., Anderson, K., Kahn, J.G., Perales, D., Guydish, J., Two- to sixfold decreased odds of HIV risk behavior associated with use of syringe exchange. J Acquir Immune Defic Syndr 31 (2002), 237–242.
27. [27] Aidala, A.A., Lee, G., Garbers, S., Chiasson, M.A., Sexual behaviors and sexual risk in a prospective cohort of HIV-positive men and women in New York City, 1994–2002: implications for prevention. AIDS Educ Prev 18 (2006), 12–32.
28. [28] Latkin, C.A., Williams, C.T., Wang, J., Curry, A.D., Neighborhood social disorder as a determinant of drug injection behaviors: a structural equation modeling approach. Health Psychol 24 (2005), 96–100.
29. [29] Bluthenthal, R., Do, D.P., Finch, B., Martinez, A., Edlin, B., Kral, A., Community characteristics associated with HIV risk among injection drug users in the San Francisco Bay Area: a multilevel analysis. J Urban Health 84 (2007), 653–666.
30. [30] Cooper, H., Moore, L., Gruskin, S., Krieger, N., The impact of a police drug crackdown on drug injectors’ ability to practice harm reduction: A qualitative study. Soc Sci Med 61 (2005), 673–684.
31. [31] Small, W., Kerr, T., Charette, J., Schechter, M.T., Spittal, P.M., Impacts of intensified police activity on injection drug users: evidence from an ethnographic investigation. Int J Drug Policy 17 (2006), 85–95.
32. [32] Logan, J., Stults, B., The persistence of segregation in the metropolis: new findings from the 2010 census. 2011, Brown University, Providence, Rhode Island.
33. [33] Massey, D., Bitterman, B., Explaining the paradox of Puerto Rican segregation. Soc Forces 64 (1985), 306–331.
34. [34] Massey, D., Denton, N., American apartheid: segregation and the making of the underclass. 1993, Harvard University Press, Cambridge, MA.
35. [35] Williams, D., Collins, C., Racial residential segregation: a fundamental cause of racial disparities in health. Public Health Rep 116 (2001), 404–416.
36. [36] Pietila, A., Not in my neighborhood: how bigotry shaped a great American city. 2010, Ivan R, Chicago.
37. [37] Cooper, H.L.F., Friedman, S.R., Tempalski, B., Friedman, R., Residential segregation and injection drug use prevalence among black adults in US metropolitan areas. Am J Public Health 97 (2007), 344–352.
38. [38] Lutfi, K., Trepka, M.J., Fennie, K.P., Ibanez, G., Gladwin, H., Racial residential segregation and risky sexual behavior among non-Hispanic blacks, 2006-2010. Soc Sci Med 140 (2015), 95–103.
39. [39] Pugsley, R.A., Chapman, D.A., Kennedy, M.G., Liu, H., Lapane, K.L., Residential segregation and gonorrhea rates in US metropolitan statistical areas, 2005-2009. Sex Transm Dis 40 (2013), 439–443.
40. [40] Buot, M.-L.G., Docena, J.P., Ratemo, B.K., Bittner, M.J., Burlew, J.T., Nuritdinov, A.R., et al. Beyond race and place: distal sociological determinants of HIV disparities. PLoS One, 9, 2014, e91711.
41. [41] Biello, K.B., Kershaw, T., Nelson, R., Hogben, M., Ickovics, J., Niccolai, L., Racial residential segregation and rates of gonorrhea in the United States, 2003–2007. Am J Public Health 102 (2012), 1370–1377.
42. [42] Cooper, H.L.F., Linton, S., Kelley, M.E., Ross, Z., Wolfe, M.E., Chen, Y.-T., et al. Racialized risk environments in a large sample of people who inject drugs in the United States. Int J Drug Policy 27 (2016), 43–55.
43. [43] Gallagher, K.M., Sullivan, P.S., Lansky, A., Onorato, I.M., Behavioral surveillance among people at risk for HIV infection in the U.S.: the National HIV Behavioral Surveillance System. Public Health Rep 122:Suppl 1 (2007), 32–38.
44. [44] CDC. HIV/AIDS Surveillance Report, 2006. 2008, Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta: U.S.
45. [45] Broz, D., Wejnert, C., Pham, H.T., DiNenno, E., Heffelfinger, J.D., Cribbin, M., et al. HIV infection and risk, prevention, and testing behaviors among injecting drug users—National HIV Behavioral Surveillance System, 20 U.S. cities, 2009. MMWR Surveill Summ 63:Suppl 6 (2014), 1–51.
46. [46] OMB. Provisional guidance on the implementation of the 1997 standards for federal data on race and ethnicity, Executive Office of the President, December 15. 2000, U.S. Office of Management and Budget Available at: https://www.whitehouse.gov/sites/default/files/omb/assets/information_and_regulatory_affairs/re_guidance2000update.pdf.
47. [47] Baral, S., Logie, C.H., Grosso, A., Wirtz, A.L., Beyrer, C., Modified social ecological model: a tool to guide the assessment of the risks and risk contexts of HIV epidemics. BMC Public Health, 13, 2013, 482.
48. [48] Adimora, A.A., Ramirez, C., Schoenbach, V.J., Cohen, M.S., Policies and politics that promote HIV infection in the Southern United States. AIDS 28 (2014), 1393–1397.
49. [49] Purtle, J., Felon disenfranchisement in the United States: a health equity perspective. Am J Public Health 103 (2013), 632–637.
50. [50] Uggen, C., Shannon, S., Manza, J., State-level estimates of felon disenfranchisement in the United States, 2010. 2012, Sentencing Project Available at: http://www.sentencingproject.org/wp-content/uploads/2016/01/State-Level-Estimates-of-Felon-Disenfranchisement-in-the-United-States-2010.pdf.
51. [51] Manza, J., Uggen, C., Punishment and democracy: disenfranchisement of nonincarcerated felons in the United States. Perspect Polit 2 (2004), 491–505.
52. [52] Medicaid and HIV: a national analysis, 2011, The Kaiser Family Foundation Available at: http://kff.org/hivaids/report/medicaid-and-hiv-a-national-analysis/.
53. [53] Southern exposure: human rights and HIV in the southern United States, 2010, Human Rights Watch Available at: https://www.hrw.org/news/2010/11/26/southern-exposure.
54. [54] Bramson, H., Des Jarlais, D.C., Arasteh, K., Nugent, A., Guardino, V., Feelemyer, J., et al. State laws, syringe exchange, and HIV among persons who inject drugs in the United States: history and effectiveness. J Public Health Policy 36 (2015), 212–230.
55. [55] Aidala, A., Cross, J.E., Stall, R., Harre, D., Sumartojo, E., Housing status and HIV risk behaviors: implications for prevention and policy. AIDS Behav 9 (2005), 251–265.
56. [56] Dickson-Gomez, J., Hilario, H., Convey, M., Corbett, A.M., Weeks, M., Martinez, M., The relationship between housing status and HIV risk among active drug users: a qualitative analysis. Subst Use Misuse 44 (2009), 139–162.
57. [57] Salazar, L., Crosby, R., Holtgrave, D., Head, S., Hadsock, B., Todd, J., et al. Homelessness and HIV-associated risk behavior among African American men who inject drugs and reside in the urban south of the United States. AIDS Behav 11 (2007), 70–77.
58. [58] Elifson, K.W., Klein, H., Sterk, C.E., Predictors of sexual risk-taking among new drug users. J Sex Res 43 (2006), 318–327.
59. [59] German, D., Nguyen, T.Q., Ogbue, C.P., Flynn, C., Condomless anal intercourse among males and females at high risk for heterosexual HIV infection. Sex Transm Dis 42 (2015), 317–323.
60. [60] MacDonald, R., Kaba, F., Rosner, Z., Vise, A., Weiss, D., Brittner, M., et al. The Rikers Island hot spotters: defining the needs of the most frequently incarcerated. Am J Public Health 105 (2015), 2262–2268.
61. [61] Bentley, R., Baker, E., Mason, K., Subramanian, S.V., Kavanagh, A.M., Association between housing affordability and mental health: a longitudinal analysis of a nationally representative household survey in Australia. Am J Epidemiol 174 (2011), 753–760.
62. [62] Jeal, N., Salisbury, C., Turner, K., The multiplicity and interdependency of factors influencing the health of street-based sex workers: a qualitative study. Sex Transm Infect 84 (2008), 381–385.
63. [63] Culhane, D.P., Lee, C.M., Wachter, S.M., Where the homeless come from: a study of the prior address distribution of families admitted to public shelters in New York City and Philadelphia. Housing Policy Debate 7 (1996), 327–365.
64. [64] Carter, G.R., From exclusion to destitution: race, affordable housing, and homelessness. Cityscape 13 (2011), 33–70.
65. [65] Johnson, R.A., African Americans and homelessness: moving through history. J Black Stud 40 (2010), 583–605.
66. [66] Freeman, L., Braconi, F., Gentrification and displacement New York City in the 1990s. J Am Plann Assoc 70 (2004), 39–52.
67. [67] Marcuse, P., Gentrification, abandonment, and displacement: connections, causes, and policy responses in New York City. Wash Univ J Urban Contemp Law, 28, 1985, 195.
68. [68] Fullilove, M., Root shock: how tearing up city neighborhoods hurts America, and what we can do about it. 2004, One World/Ballantine Books, New York.
69. [69] Kelly, S.M., Schwartz, R.P., O'Grady, K.E., Gandhi, D., Jaffe, J.H., Impact of methadone with v. without drug abuse counseling on HIV risk: 4- and 12-month findings from a clinical trial. J Addict Med 6 (2012), 145–152.
70. [70] Latka, M.H., Wilson, T.E., Cook, J.A., Bacon, M.C., Richardson, J.L., Sohler, N., et al. Impact of drug treatment on subsequent sexual risk behavior in a multisite cohort of drug-using women: a report from the women's interagency HIV study. J Subst Abuse Treat 29 (2005), 329–337.
71. [71] Arndt, S., Acion, L., White, K., How the states stack up: disparities in substance abuse outpatient treatment completion rates for minorities. Drug Alcohol Depend 132 (2013), 547–554.
72. [72] Alexander, M., The new Jim Crow: mass incarceration in the age of colorblindness. 2010, The New Press, New York, NY.
73. [73] Crawford, N.D., Rudolph, A.E., Fuller, C.M., Racial/ethnic differences in recent drug detoxification enrollment and the role of discrimination and neighborhood factors. Subst Use Misuse 49 (2013), 124–133.
74. [74] Guerrero, E.G., Kao, D., Racial/ethnic minority and low-income hotspots and their geographic proximity to integrated care providers. Subst Abuse Treat Prev Policy, 8, 2013, 34.
75. [75] Oggins, J., Engaging minority men at HIV risk in integrated mental health and drug treatment. J Psychoactive Drugs 41 (2009), 163–171.
76. [76] Metzger, D.S., Donnell, D., Celentano, D.D., Jackson, J.B., Shao, Y., Aramrattana, A., et al. Expanding substance use treatment options for HIV prevention with buprenorphine–naloxone: HIV Prevention Trials Network 058. J Acquir Immune Defic Syndr 68 (2015), 554–561.
77. [77] Wong, K.H., Lee, S.S., Lim, W.L., Low, H.K., Adherence to methadone is associated with a lower level of HIV-related risk behaviors in drug users. J Subst Abuse Treat 24 (2003), 233–239.
78. [78] Bluthenthal, R.N., Kral, A.H., Lorvick, J., Erringer, E.A., Edlin, B.R., Harm reduction and needle exchange programmes. Lancet 351 (1998), 1819–1820.
79. [79] Cox, G.M., Lawless, M.C., Cassin, S.P., Geoghegan, T.W., Syringe exchanges: a public health response to problem drug use. Ir Med J 93 (2000), 143–146.
80. [80] Gibson, D.R., Flynn, N.M., Perales, D., Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS 15 (2001), 1329–1341.
81. [81] Monterroso, E.R., Hamburger, M.E., Vlahov, D., Des Jarlais, D.C., Ouellet, L.J., Altice, F.L., et al. Prevention of HIV infection in street-recruited injection drug users. J Acquir Immune Defic Syndr 25 (2000), 63–70.
82. [82] Holtgrave, D.R., Pinkerton, S.D., Jones, T.S., Lurie, P., Vlahov, D., Cost and cost-effectiveness of increasing access to sterile syringes and needles as an HIV prevention intervention in the United States. J Acquir Immune Defic Syndr Hum Retrovirol 18:Suppl 1 (1998), S133–S138.
83. [83] Latkin, C.A., Forman, V.L., Patterns of needle acquisition and sociobehavioral correlates of needle exchange program attendance in Baltimore, Maryland, U.S.A. J Acquir Immune Defic Syndr 27 (2001), 398–404.
84. [84] Braine, N., Acker, C., Goldblatt, C., Yi, H., Friedman, S., Desjarlais, D.C., Neighborhood history as a factor shaping syringe distribution networks among drug users at a U.S. syringe exchange. Soc Networks 30 (2008), 235–246.
85. [85] Werb, D., Wood, E., Small, W., Strathdee, S., Li, K., Montaner, J., et al. Effects of police confiscation of illicit drugs and syringes among injection drug users in Vancouver. Int J Drug Policy 19 (2008), 332–338.
86. [86] Burt, R.D., Hagan, H., Sabin, K., Thiede, H., Evaluating respondent-driven sampling in a major metropolitan area: comparing injection drug users in the 2005 Seattle area National HIV Behavioral Surveillance system survey with participants in the RAVEN and Kiwi Studies. Ann Epidemiol, 20, 2010, 159.
87. [87] Abdul-Quader, A.S., Heckathorn, D.D., McKnight, C., Bramson, H., Nemeth, C., Sabin, K., et al. Effectiveness of respondent-driven sampling for recruiting drug users in New York City: findings from a pilot study. J Urban Health 83 (2006), 459–476.
88. [88] Malekinejad, M., McFarland, W., Vaudrey, J., Raymond, H.F., Accessing a diverse sample of injection drug users in San Francisco through respondent-driven sampling. Drug Alcohol Depend 118 (2011), 83–91.
89. [89] Duncan, D.T., Kawachi, I., Subramanian, S.V., Aldstadt, J., Melly, S.J., Williams, D.R., Examination of how neighborhood definition influences measurements of youths’ access to tobacco retailers: a methodological note on spatial misclassification. Am J Epidemiol 179 (2014), 373–381.
90. [90] Chaix, B., Merlo, J., Subramanian, S.V., Lynch, J., Chauvin, P., Comparison of a spatial perspective with the multilevel analytical approach in neighborhood studies: the case of mental and behavioral disorders due to psychoactive substance use in Malmo, Sweden, 2001. Am J Epidemiol 162 (2005), 171–182.
91. [91] Chaix, B., Merlo, J., Chauvin, P., Comparison of a spatial approach with the multilevel approach for investigating place effects on health: the example of healthcare utilisation in France. J Epidemiol Community Health 59 (2005), 517–526.
92. [1] Browne, W.J., Subramanian, S.V., Jones, K., Goldstein, H., Variance partitioning in multilevel logistic models that exhibit overdispersion. J R Stat Soc Ser A Stat Soc 168 (2005), 599–613.
93. [2] Goldstein, H., Browne, W., Rasbash, J., Partitioning variation in multilevel models. Understanding Stat 1 (2002), 223–231.
94. [3] Rabe-Hesketh, S., Skrondal, A., Multilevel and longitudinal modeling using Stata. Second Edition, 2008, Stata Press, College Station, Texas.